Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Salter

Showing results (371-380 of 393) with videos related to

Pageof 40
Sort By:
Circulation|November 18, 2011
Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosisMarc Richard Dweck, Charlotte Jones, Nikhil V Joshi, et al.
The Review of Scientific Instruments|August 7, 2009
A zero-gravity instrument to study low velocity collisions of fragile particles at low temperaturesD M Salter, D Heisselmann, G Chaparro, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1996
A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer ConsortiumE C Halperin, J Herndon, S C Schold, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)Christopher P Mussari, Dharmpal S Dodd, Ratna Kumar Sreekantha, et al.
ACS Medicinal Chemistry Letters|May 19, 2022
Identification of 2-Pyridinylindole-Based Dual Antagonists of Toll-like Receptors 7 and 8 (TLR7/8)Ratna Kumar Sreekantha, Christopher P Mussari, Dharmpal S Dodd, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2016
Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitorsRajeev S Bhide, James Neels, Lan-Ying Qin, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phenyl)pyrrolidines as novel RORγt inverse agonistsBin Jiang, James J-W Duan, Sylwia Stachura, et al.
Molecular Oncology|May 26, 2025
Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcomaPiotr J Manasterski, Molly R Danks, John P Thomson, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2017
Discovery of highly potent, selective, covalent inhibitors of JAK3James Kempson, Damaso Ovalle, Junqing Guo, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 28, 2015
Dual Inhibition of Interleukin-23 and Interleukin-17 Offers Superior Efficacy in Mouse Models of AutoimmunityPaul R Mangan, Linhui Julie Su, Victoria Jenny, et al.
Pageof 40

Showing results (371-380 of 393) with videos related to

Sort By:
Pageof 40
Circulation|November 18, 2011
Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosisMarc Richard Dweck, Charlotte Jones, Nikhil V Joshi, et al.
The Review of Scientific Instruments|August 7, 2009
A zero-gravity instrument to study low velocity collisions of fragile particles at low temperaturesD M Salter, D Heisselmann, G Chaparro, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1996
A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer ConsortiumE C Halperin, J Herndon, S C Schold, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)Christopher P Mussari, Dharmpal S Dodd, Ratna Kumar Sreekantha, et al.
ACS Medicinal Chemistry Letters|May 19, 2022
Identification of 2-Pyridinylindole-Based Dual Antagonists of Toll-like Receptors 7 and 8 (TLR7/8)Ratna Kumar Sreekantha, Christopher P Mussari, Dharmpal S Dodd, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2016
Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitorsRajeev S Bhide, James Neels, Lan-Ying Qin, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phenyl)pyrrolidines as novel RORγt inverse agonistsBin Jiang, James J-W Duan, Sylwia Stachura, et al.
Molecular Oncology|May 26, 2025
Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcomaPiotr J Manasterski, Molly R Danks, John P Thomson, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2017
Discovery of highly potent, selective, covalent inhibitors of JAK3James Kempson, Damaso Ovalle, Junqing Guo, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 28, 2015
Dual Inhibition of Interleukin-23 and Interleukin-17 Offers Superior Efficacy in Mouse Models of AutoimmunityPaul R Mangan, Linhui Julie Su, Victoria Jenny, et al.
Pageof 40